Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 32.81
-1.38 (-4.04%)
Jun 2, 2026, 3:00 PM CST
SHA:603590 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 168.68 | 165.97 | 42.22 | 150.45 | 101.49 | 147.99 |
Depreciation & Amortization | 32.38 | 32.38 | 36.46 | 42.94 | 38.72 | 36.14 |
Other Amortization | 4.09 | 4.09 | 0.53 | 0.83 | 0.55 | 0.09 |
Loss (Gain) From Sale of Assets | 0.55 | 0.55 | 0.01 | 0.13 | 0.01 | -0.02 |
Asset Writedown & Restructuring Costs | 0.02 | 0.02 | 105.44 | - | 4.06 | 0.01 |
Loss (Gain) From Sale of Investments | -21.87 | -21.87 | -17.66 | 7.22 | 7.65 | -35.64 |
Provision & Write-off of Bad Debts | 11.28 | 11.28 | 4.93 | 5.59 | 1.87 | 1.21 |
Other Operating Activities | 63.6 | 14.21 | -10.08 | 42.93 | 24.82 | 18.53 |
Change in Accounts Receivable | -62.36 | -62.36 | 32.67 | -35.74 | -64.94 | -22.56 |
Change in Inventory | 17.91 | 17.91 | -24.05 | -11.47 | 9.53 | -13.08 |
Change in Accounts Payable | -63.63 | -63.63 | -26.55 | 10.88 | 0.71 | -63.98 |
Change in Income Taxes | - | - | - | - | - | -14.7 |
Change in Other Net Operating Assets | 8.98 | 8.98 | 21.88 | 18.62 | -1.64 | 1.39 |
Operating Cash Flow | 167.79 | 115.68 | 172.25 | 199.35 | 119.69 | 56.22 |
Operating Cash Flow Growth | 75.32% | -32.84% | -13.60% | 66.56% | 112.91% | -3.75% |
Capital Expenditures | -39.88 | -53.45 | -104.02 | -100.91 | -96.31 | -164.65 |
Sale of Property, Plant & Equipment | 0.61 | 0.61 | 0.03 | 0.01 | 0 | 0.05 |
Cash Acquisitions | - | - | - | - | - | -360 |
Divestitures | - | - | - | - | - | -0 |
Investment in Securities | 61.14 | 75.94 | -114.24 | -364.51 | -251.86 | -113.02 |
Other Investing Activities | 22.65 | 21.19 | 19.83 | 17.7 | 23.66 | 9.87 |
Investing Cash Flow | 44.52 | 44.29 | -198.4 | -447.72 | -324.51 | -627.75 |
Short-Term Debt Issued | - | - | - | - | - | 3.2 |
Long-Term Debt Issued | - | 298.87 | 217.55 | 147.76 | - | - |
Total Debt Issued | 303.18 | 298.87 | 217.55 | 147.76 | - | 3.2 |
Short-Term Debt Repaid | - | - | - | - | - | -27.42 |
Long-Term Debt Repaid | - | -187.99 | -179.41 | -11.56 | -9.94 | -6.46 |
Total Debt Repaid | -198.39 | -187.99 | -179.41 | -11.56 | -9.94 | -33.89 |
Net Debt Issued (Repaid) | 104.8 | 110.87 | 38.14 | 136.19 | -9.94 | -30.69 |
Issuance of Common Stock | - | - | 8.87 | 42.4 | - | - |
Repurchase of Common Stock | -25.83 | -25.83 | -2.6 | -0.03 | - | -124.64 |
Common Dividends Paid | -103.06 | -102.39 | -53.49 | -34.95 | -46.95 | -55.61 |
Other Financing Activities | -42.88 | - | 0.82 | - | - | 268.69 |
Financing Cash Flow | -66.97 | -17.35 | -8.27 | 143.62 | -56.89 | 57.76 |
Foreign Exchange Rate Adjustments | -0.11 | -0.03 | -2.82 | -1.37 | -0.75 | -0.15 |
Net Cash Flow | 145.23 | 142.6 | -37.24 | -106.11 | -262.46 | -513.93 |
Free Cash Flow | 127.91 | 62.23 | 68.22 | 98.44 | 23.38 | -108.43 |
Free Cash Flow Growth | - | -8.79% | -30.70% | 321.05% | - | - |
Free Cash Flow Margin | 13.93% | 6.80% | 8.27% | 10.70% | 2.70% | -13.39% |
Free Cash Flow Per Share | 0.80 | 0.39 | 0.44 | 0.63 | 0.15 | -0.69 |
Cash Income Tax Paid | 108.43 | 84.95 | 11.53 | 51.86 | 45.63 | 71.81 |
Levered Free Cash Flow | 185.43 | 60.82 | 35.96 | 56.35 | -20.66 | -523.66 |
Unlevered Free Cash Flow | 190.31 | 65.52 | 39.81 | 58.08 | -20.12 | -522.78 |
Change in Working Capital | -90.95 | -90.95 | 10.41 | -50.74 | -59.49 | -112.1 |